NUS1

Chr 6ARAD

NUS1 dehydrodolichyl diphosphate synthase subunit

Also known as: C6orf68, CDG1AA, MGC:7199, MRD55, NgBR, TANGO14

This gene encodes a type I single transmembrane domain receptor, which is a subunit of cis-prenyltransferase, and serves as a specific receptor for the neural and cardiovascular regulator Nogo-B. The encoded protein is essential for dolichol synthesis and protein glycosylation. This gene is highly expressed in non-small cell lung carcinomas as well as estrogen receptor-alpha positive breast cancer cells where it promotes epithelial mesenchymal transition. This gene is associated with the poor prognosis of human hepatocellular carcinoma patients. Naturally occurring mutations in this gene cause a congenital disorder of glycosylation and are associated with epilepsy. A knockout of the orthologous gene in mice causes embryonic lethality before day 6.5. Pseudogenes of this gene have been defined on chromosomes 13 and X. [provided by RefSeq, May 2017]

OMIMResearchGenerating clinical summary…
LOFmechanismAR/ADLOEUF 0.252 OMIM phenotypes
Clinical SummaryNUS1
🧬
Gene-Disease Validity (ClinGen)
progressive myoclonus epilepsy · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.98). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
90 unique Pathogenic / Likely Pathogenic· 235 VUS of 511 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.25LOEUF
pLI 0.981
Z-score 3.23
OE 0.00 (0.000.25)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
0.88Z-score
OE missense 0.80 (0.690.93)
126 obs / 156.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.00 (0.000.25)
00.351.4
Missense OE?0.80 (0.690.93)
00.61.4
Synonymous OE?1.02
01.21.6
LoF obs/exp: 0 / 12.1Missense obs/exp: 126 / 156.9Syn Z: -0.14
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongNUS1-related epilepsy and intellectual disabilityLOFAD

This gene — mechanism propensity

DN
0.3594th %ile
GOF
0.3094th %ile
LOF
0.72top 10%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · 1 literature citation · 88% of P/LP variants are LoF · LOEUF 0.25 · ClinGen HI: Sufficient evidence for dosage pathogenicity

Literature Evidence

LOFTwo patients were found by whole-genome sequencing of 197 individuals with developmental epileptic encephalopathy; the third patient was found by clinical exome sequencing from another patient cohort. Studies of the variants and studies of patients cells were not performed, but Hamdan et al. (2017) 1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 29100083

ClinVar Variant Classifications

511 submitted variants in ClinVar

Classification Summary

Pathogenic57
Likely Pathogenic33
VUS235
Likely Benign157
Benign13
Conflicting11
57
Pathogenic
33
Likely Pathogenic
235
VUS
157
Likely Benign
13
Benign
11
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
50
1
6
0
57
Likely Pathogenic
29
3
1
0
33
VUS
2
224
7
2
235
Likely Benign
0
3
53
101
157
Benign
0
1
10
2
13
Conflicting
11
Total8123277105506

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

30 pathogenic / likely-pathogenic (of 36) ClinVar copy-number / structural variants overlap NUS1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

NUS1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →